Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Net Income (Continuing Operations) : ¥335 Mil (TTM As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Jiangsu Kanion Pharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Jiangsu Kanion Pharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ¥86 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥335 Mil.

Jiangsu Kanion Pharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Jiangsu Kanion Pharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Kanion Pharmaceutical Co Net Income (Continuing Operations) Chart

Jiangsu Kanion Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

274.03

324.35

441.92

444.06

380.92

Jiangsu Kanion Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															131.43	139.87	92.69	16.94	85.55

Jiangsu Kanion Pharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥335 Mil.

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Jiangsu Kanion Pharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Jiangsu Kanion Pharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Kanion Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001

Website

http://www.kanion.com

Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.

Executives

Pan Yu	Director
Wang Chuan Lei	Director
Yang Yong Chun	Director
Liu Quan	Director
Wang Zhen Zhong	Director
Chen Xue Bin	Director
Xu Dian Hong	Director
Wu Yun	Director
Gao Hai Xin	Director
Xiao Wei	Director
Wan Yan Huan	senior management
Xia Yue	Director
Yang Yin	Director

Jiangsu Kanion Pharmaceutical Co Headlines

No Headlines